236 related articles for article (PubMed ID: 20695882)
1. The versatility of HDL: a crucial anti-inflammatory regulator.
Säemann MD; Poglitsch M; Kopecky C; Haidinger M; Hörl WH; Weichhart T
Eur J Clin Invest; 2010 Dec; 40(12):1131-43. PubMed ID: 20695882
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoprotein: a potent inhibitor of inflammation.
Murphy AJ; Woollard KJ
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):710-8. PubMed ID: 19930423
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease.
Besler C; Heinrich K; Riwanto M; Lüscher TF; Landmesser U
Curr Pharm Des; 2010 May; 16(13):1480-93. PubMed ID: 20196740
[TBL] [Abstract][Full Text] [Related]
4. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
Kontush A; Chapman MJ
Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
[TBL] [Abstract][Full Text] [Related]
5. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
Vaziri ND
J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
[TBL] [Abstract][Full Text] [Related]
6. Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence.
Nofer JR; Walter M; Assmann G
Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1071-86. PubMed ID: 16292998
[TBL] [Abstract][Full Text] [Related]
7. Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium.
Andrews KL; Moore XL; Chin-Dusting JP
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):736-42. PubMed ID: 20374256
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerotic risk factors in cardiovascular disease.
LaRosa JC
J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
[TBL] [Abstract][Full Text] [Related]
9. Darapladib: an emerging therapy for atherosclerosis.
Corson MA
Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):241-8. PubMed ID: 20660537
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis regression and high-density lipoproteins.
Lee JM; Choudhury RP
Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1325-34. PubMed ID: 20828355
[TBL] [Abstract][Full Text] [Related]
11. High-density lipoproteins, inflammation and oxidative stress.
Tabet F; Rye KA
Clin Sci (Lond); 2009 Jan; 116(2):87-98. PubMed ID: 19076062
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoproteins: an emerging target in the prevention of cardiovascular disease.
Cutri BA; Hime NJ; Nicholls SJ
Cell Res; 2006 Oct; 16(10):799-808. PubMed ID: 17016470
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein function recent advances.
Ansell BJ; Watson KE; Fogelman AM; Navab M; Fonarow GC
J Am Coll Cardiol; 2005 Nov; 46(10):1792-8. PubMed ID: 16286161
[TBL] [Abstract][Full Text] [Related]
14. HDL function as a target of lipid-modifying therapy.
Watson KE; Ansell BJ; Watson AD; Fonarow GC
Rev Cardiovasc Med; 2007; 8(1):1-8. PubMed ID: 17401296
[TBL] [Abstract][Full Text] [Related]
15. [Exercise therapy for prevention of atherosclerosis].
Sasaki J
Nihon Rinsho; 2011 Jan; 69(1):119-24. PubMed ID: 21226271
[TBL] [Abstract][Full Text] [Related]
16. HDL-cholesterol: is it really good? Differences between apoA-I and HDL.
Santos-Gallego CG; Ibanez B; Badimon JJ
Biochem Pharmacol; 2008 Aug; 76(4):443-52. PubMed ID: 18547543
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
Malle E; Marsche G; Panzenboeck U; Sattler W
Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
[TBL] [Abstract][Full Text] [Related]
18. Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension.
Bühler FR; Tkachuk VA; Hahn AW; Resink TJ
J Hypertens Suppl; 1991 Dec; 9(6):S28-36. PubMed ID: 1818968
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic acid and other therapies for raising high-density lipoprotein.
Carlson LA
Curr Opin Cardiol; 2006 Jul; 21(4):336-44. PubMed ID: 16755203
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoprotein subfractions--what the clinicians need to know.
Pirillo A; Norata GD; Catapano AL
Cardiology; 2013; 124(2):116-25. PubMed ID: 23428644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
